Showing 22,152 results

Filters Content type: Editors' picks
Pharmaceutical industry

The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C

Editor's pick
Forbes
17 January 2017
New & experimental HIV treatments

SA can save billions with new HIV drug combination

Editor's pick
Health24
17 January 2017
Self-testing & home testing

DIY test for HIV comes to a pharmacy near you

Editor's pick
Health-e
17 January 2017
Sexually transmitted infections epidemiology

HIV treatment might boost susceptibility to syphilis, say researchers

Editor's pick
Eurekalert Medicine & Health
17 January 2017
The search for a cure

Converging Roads Between HIV and Cancer Research

Editor's pick
International AIDS Society
16 January 2017
PrEP

Zimbabwe: Zim to Roll Out Pre-Exposure HIV Pill

Editor's pick
AllAfrica
16 January 2017
HIV & criminal law

Guide to prosecuting HIV cases ‘undermining’ public health, critics say

Editor's pick
Toronto Star
16 January 2017
HIV & criminal law

Criminalization of HIV non-disclosure a bigger burden on women, advocates say

Editor's pick
Toronto Star
16 January 2017
PrEP

HIV diagnoses falling steeply, early figures show: London clinics see hope in increased use of pre-exposure prophylaxis

Editor's pick
Financial Times
13 January 2017
Harm reduction

Why addicts take drugs in 'fix rooms'

Editor's pick
BBC
12 January 2017
Smoking

Worried About HIV and Aging? The First Thing to Do Is Stop Smoking

Editor's pick
The Body
12 January 2017
Hepatitis B

European Commission Grants Marketing Authorization for Gilead’s Vemlidy® (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus Infection

Editor's pick
Gilead press release
12 January 2017
The biology of HIV transmission

Bacterial communities of female genital tract impact HIV infection risk

Editor's pick
Ragon Institute
12 January 2017
Undetectable viral load & treatment as prevention

London doctors on verge of defeating HIV thanks to new programme

Editor's pick
London Evening Standard
11 January 2017
Religion & faith

Knights of Malta condom scandal stretches from Myanmar to the Vatican

Editor's pick
The Guardian
11 January 2017
Activism & civil society

Fighting Trump: HIV Advocates to Watch in 2017

Editor's pick
My Fabulous Disease
11 January 2017
Smoking

Can E-Cigarettes Be a Harm Reduction Approach for HIV-Positive Smokers?

Editor's pick
The Body Pro
11 January 2017
Finance & funding

Global health is good business — Trump should get in the prosperity

Editor's pick
The Hill
10 January 2017
PrEP

CDC guidelines for HIV prevention regimen may not go far enough, study suggests

Editor's pick
EurekAlert
10 January 2017
The search for a cure

Gilead Awards More Than $22 Million in Grants to Support HIV Cure Research

Editor's pick
Gilead press release
10 January 2017
Improving HIV care

A sexual health revolution – how to unleash the power of collaboration

Editor's pick
Health21
10 January 2017
New & experimental hepatitis C treatment

Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P) for Chronic Hepatitis C Achieved High SVR12 Rates in Genotype 1 Japanese Patients

Editor's pick
AbbVIe press release
9 January 2017
Activism & civil society

Community Mobilization: An Assessment of Mechanisms and Barriers at Community-Based and AIDS Service Organizations in Nine U.S. Metropolitan Areas

Editor's pick
TAG
9 January 2017
Health services & systems

Exhibit A for Republican Obamacare repeal challenge: people with HIV

Editor's pick
Reuters
9 January 2017